Fig. 1From: Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell diseaseCreatinine (A), estimated glomerural fitration rate (e-GFR) (B), Alanine amino-trasnferase ALT (C) and aspartate amino transferase (AST) (D) at basal, during therapy and up to 30 days after multimodal analgesic therapy with ketorolac plus tramadolBack to article page